ESG PLAN AND SUSTAINABILITY REPORTS

The PharmaNutra Group views sustainability as a strategic pillar of its business model, integrating it into every aspect of its operations. This vision translates into a genuine commitment to protecting the environment, enhancing the well-being of people, and creating shared value for all stakeholders.

The Group’s approach to sustainability is built on three core dimensions:
1. Environmental sustainability: Reducing the environmental impact through efficient production processes, eco-friendly packaging and initiatives aimed at saving energy.
2. Social sustainability: Enhancing people’s well-being through products that improve quality of life and company policies that care about employees and local communities.
3. Economic sustainability: Creating lasting value through responsible growth and the mindful use of resources.

ESG Strategic Plan and Sustainability Report


The ESG Strategic Plan, along with the Sustainability Report, serves as a key testament to the company’s dedication to tackling the environmental, social and economic challenges of today.
Through the ESG Strategic Plan, the Group outlines its strategic direction to stakeholders and sets clear objectives to achieve in the medium to long term, on the understanding that sustainability is an ongoing journey, not a final destination.
The Plan is structured around six key areas:
1. GOVERNANCE - Driving sustainable success
2. PEOPLE - Fostering ESG engagement, awareness and ownership
3. ENVIRONMENT - Ensuring efficient resource management and reducing environmental impact
4. INNOVATION - Protecting intellectual property, patents and raw materials.
5. COMMUNITY - Contributing to the well-being and enhancing the quality of life in local communities
6. VALUE CHAIN - Strengthening the supply chain from an ESG perspective
The annual Sustainability Report demonstrates the Group's commitment, documenting its achievements and outlining future goals in a transparent way, with the goal of inspiring a corporate culture that increasingly prioritises sustainability. This document serves not only as a regulatory requirement for many companies but also as an opportunity to:
Monitor progress: Gathering and analysing data on environmental, social and economic performance to assess the effectiveness of the strategies in place.
Engaging stakeholders: Providing clear and accessible information to shareholders, customers, partners, employees and communities, strengthening trust and fostering positive sentiment.
Driving continuous improvement: Identifying areas for growth and setting new goals to promote responsible and sustainable development.

Documents available

UN 2030 Agenda: our contribution

In line with its vision and mission, the PharmaNutra Group has committed to the UN 2030 Agenda for Sustainable Development, focusing on how the company can more directly contribute to the Sustainable Development Goals (SDGs).
The 2030 Agenda consists of 17 Sustainable Development Goals, broken down into 169 targets that address the three key dimensions: economic, social and environmental. These goals involve all nations and sectors, from private companies to the public sector, aiming to eradicate poverty, reduce inequality, combat climate change and build societies that uphold human rights.
Below are the key material issues identified by the PharmaNutra Group, linked to the relevant SDGs, demonstrating the company’s potential contribution to achieving these global goals. Through a document available on the official GRI Standards website, the PharmaNutra Group has outlined the correlation between the GRIs applied and the specific SDGs, highlighting how each theme aligns with the SDGs of the 2030 Agenda.

UN 2030 Agenda: our contribution